Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
12/3/2024
NHC Minister Meets with Sanofi and BioMérieux Bosses to Strengthen Si...
12/3/2024
Sanofi Allocates €1 Billion for New Insulin Manufacturing Facility in...
12/3/2024
CMS Gains Licenses Class 1 New Drug Targeting Gout and Hyperuricemia f...
12/2/2024
UCB Closes Divestment from Neurology and Allergy Portfolio in China, ...
12/2/2024
Allink Biotherapeutics Secures $42M Series A to Advance Oncology and I...
12/2/2024
Hangzhou Jiuyuan Gene Engineering Debuts on Hong Kong Stock Exchange
12/2/2024
Merck's Recarbrio Approved in China for Severe Bacterial Pneumonia
12/2/2024
Shanghai Cell Therapy Group Submits Application Proof for Hong Kong Li...
12/2/2024
Affinity Biopharma Raises Over CNY 400M in Series B2 to Advance Tumor-...
12/2/2024
Zambon's Xadago (Safinamide) Gains Chinese Approval for Parkinson's Di...
12/2/2024
Nanjing Leads Biolabs Files for Hong Kong IPO
11/28/2024
AstraZeneca's Enhertu Secures Reimbursement Listing Despite Ongoing Pr...
11/28/2024
BeOne Secures EU Approval for First-Line Checkpoint Blocker
11/27/2024
Policy Change Set to Advance Cell and Gene Therapy in China
11/27/2024
Kelun's Merck-partnered TROP2 ADC sac-TMT Approved for Marketing in C...
11/25/2024
DP Tech and Lepu Biopharma Enter ADC Partnership
11/25/2024
BRL Medicine Secures ~CNY 200M in Series B+ Financing to Advance Gene ...
11/25/2024
TG ImmunoPharma Completes Series Pre-A+ Financing to Accelerate Immuno...
11/25/2024
Junshi Secures Licensing Deal for Bispecific Fusion Proteins
11/25/2024
Hanx Biopharma Submits IPO Application to HKSE
11/25/2024
Kanglin Biotech Announces $20M Series A Financing to Advance Gene Ther...
11/22/2024
Hua Medicine to Terminate China Commercialization Agreement with Bayer...
11/21/2024
Sino Biopharma Strengthens Oncology Portfolio with Investment in LaNov...
11/21/2024
RDPAC Reinforces Strategic Commitment to China's Pharmaceutical Market
11/21/2024
Pfizer and Zai Lab Announce Strategic Deal on Antibacterial Drug XACDU...
11/21/2024
CStone and Pharmalink Enter into Strategic Partnership for Sugemalimab...
11/20/2024
Eli Lilly Partners with Laekna to Develop Next-Generation Obesity Drug...
11/20/2024
J&J and Merck Restructure Operations in China Amid Market Challenges
11/18/2024
China's Biopharma Boom: A Surge in Innovation and Drug Approvals
11/18/2024
HCW Bio and WY Bio Enter License and Co-Development Deal
Page:
13
/
23
Total number of articles:
663
:
[First]
[<<]
[11]
[12]
[13]
[14]
[15]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit